AU602149B2 - Apatite immobilized glucanase and the like, and method of preparing the same - Google Patents
Apatite immobilized glucanase and the like, and method of preparing the same Download PDFInfo
- Publication number
- AU602149B2 AU602149B2 AU74601/87A AU7460187A AU602149B2 AU 602149 B2 AU602149 B2 AU 602149B2 AU 74601/87 A AU74601/87 A AU 74601/87A AU 7460187 A AU7460187 A AU 7460187A AU 602149 B2 AU602149 B2 AU 602149B2
- Authority
- AU
- Australia
- Prior art keywords
- apatite
- glucanase
- protein
- immobilized
- lysozyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
ZXMAnis80doNW1NFrHra33/V 'Id OL ~U I I 149 S F Ref: 29808 FORM COMMONWEALTH OF AUSTRALIA PATENTS ACT 1952 COMPLETE SPECIFICATION
(ORIGINAL)
FOR OFFICE USE: Class Int Class 4* C.o Ar r Complete Specification Lodged: Accepted: Published: Priority: Related Art: This document contains the amendments made under Section 49 and is correct for printing Name and Address of Applicant: Address for Service: Dental Kagaku Kabushiki Kaisha Tsukijichuo Bldg.
2-11-10, Tsukiji Chuo-ku, Tokyo
JAPAN
Spruson Ferguson, Patent Attorneys Level 33 St Martins Tower, 31 Market Street Sydney, New South Wales, 2000, Australia r.
Complete Specification for the invention entitled: Apatite immobilized preparing the same glucanase and the like, and method of The following statement is a full description of this invention, including the best method of performing it known to me/us 5845/3 23 JUN 1987 Svdne 5845/2 Abstract of the Disclosure An apatite having glucanase immobilized therein is provided as well as a method of preparing an apatite having glucanase immobilized therein, which method comprises adding dropwise glutaraldehyde to an aqueous solution in which glucanase, protein and apatite are present in a mixed state.
t r ftf f ft ft t -t t ft ft f r r t C 1 I 'S I.L 11 Ii 'S'I )II JLI\ 'I i fL n I j S&F REF: 29808 5881/2 TITLE OF THE INVENTION Apatite immobilized glucanase and the like, and method of preparing the same BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to apatite having glucanase immobilized therein, and to a method of immobilizing glucanase in apatite.
"Glucanase" which is a general term for glucan- JO decomposing enzymes includes various enzymes. It is S understood, however, that the term "glucanase" used ti S herein refers to levanase which decomposes levan, dextranase which decomposes dextran and mutanase which decomposes mutan. Further, the term "apatite" refers to both hydroxyapatite and fluoro-apatite.
It is well-known that the occurrence of dental caries is due to dental plaque formed by way of polysaccharides such as, levan, dextran and mutan which are produced by a variety of oral bacteria.
.0 Consequently, it is believed that the polysaccharides produced by such bacteria should be removed to suppress SIt the occurrence of dental plaque for the purpose of preventing dental caries. The present invention relates to apatite having immobilized enzymes for the decomposition of polysaccharides associated with dental caries, 1 Rand to a method of preparing such apatite.
Description of the Prior Art.
In the prior art, various methods have been developed for removing dental plaque in order to prevent dental caries. Such methods include scraping-off of dental plaque with the use of polishing agent such as zeolite, calcium carbonate, alumina and silica, using dextranase together with a stabilizer, etc. Until now, however, there has been no method of immobilizing enzyme, which are capable of decomposing polysaccharide responsible for the occurrence of dental caries such as levanase, S mutanase and dextranase, with apatite, and there has been no apatite in which such enzymes are immobilized, as t contemplated in the present invention.
Glucanase is an enzyme and relatively unstable.
S Accordingly, when glucanase is mixed with a dentifrice without being modified, its activity decreases with 4r time and eventually vanishes. Dextranase is now used Swith dentifrice, and varjjus stabilizers are produced I O to prevent the deactivation thereof. For instance, combinations of dextranase with aluminium oxide, carvone or i-mentol, and gelatin or peptone are proposed in the S specifications of Japanese Patent Application Laid-Open Nos. 56-63915 and 56-110609 and Japanese Patent Publication No. 52-49005. Since dentifrice is designed to be used in the mouth, various restrictions are impose, including considerations concerning the influence upon the human 2 body and the demand for a refreshing feeling after use.
Since it is a matter of course that such restrictions are placed upon the stabilizers used, the selection of the stabilizers involves difficult problems. Use of other enzymes besides dextranase possess the same problems as the use of dextranase.
Summary of the Invention As a result of intensive and extensive studies made on the stabilization of glucose, it has been found that the immobilization of glucanase with apatite, which is used as a polishing agent yields glucanase which does not require a stabilizer and which exhibits activity over an extended period. The present invention provides apatite haveing glucanase immobilized therein and a method of preparing such apatite.
It is well-known that there is an enzyme-immobilizing method based on the fact that hydroxyapatite, activecarbon, kaolinite, terra abla and the like physically absorb enzymes for immobilization, and it is generally S o known that the immobilized enzymes are so stable that they show a lesser change in activity with time compared with an untreated enzyme and are convenient to handle. It has thus been long known that apatite firmly adsorbs and bonds thereto a certain type of protein. Based on the consideration that the immobilization of glucanase may lead to a reduction in activity change with time.
-3- I; 4 it is presumed that, if glucanase is immobilized with apatite used as the polishing agent for dentifrice by the physical adsorption method, immobilized glucanase might be obtained easily and it might then be possible to obtain a desirable dentifrice material which combines a polishing capability with a polysaccharide-decomposing capability, and dispenses with any selection of stabilizer. As a result of studies made on such a presumption, it has been found that the adsorption and immobilization of glucanase on apatite is unfeasible due to the fact that the adsorption of glucanase to apatite is extremely limited. For this reason, further studies were made on the immobilization of glucanase by way of protein that is firmly adsorbed to and bonded to apatite and, in consequence, apatite having glucanase immobilized therein and a method of Spreparing the same were found.
According to this invention there is provided a method of preparing 1 5 an ipatite having glucanase immobilized therein, which comprises adding dropwise glutaraldehyde to an aqueous solution in which glucanase, protein and apatite are present in a mixed state, wherein the protein is firmly adsorbed to the apatite prior to the addition of the glutaraldehyde.
Apatite is suspended in an aqueous solution or in a phosphate buffer solution having a concentration of 0.01 to 0.05 moles in which glucanase and protein showing strong adsorption to apatite and having no adverse influence upon the human body are dissolved, and a bifunctional aldehyde is.
then added dropwise *3 1369S 36S i: under vigorous agitation to the resulting suspension at below room temperature. The protein used may be selected from albumin, casein, lysozyme, cytochrome C and the like. Depending upon the type of protein, there is a difference in the titer of the resulting immobilized enzyme and the bonding force with respect to apatite.
As will be appreciated from the results of the elution test to be given later, however, preference is given to lysozyme, cytochrome C and the like. The glucanase rj used may be selected arbitrarily from levanase, dextranase and mutanase, as already mentioned. Optionally, mixtures of such enzymes may be used. The reaction involved take place at a pH level at which no decomposition of apatite occurs, at a pH level of 5.6 or higher. However, as a higher pH has an adverse influence upon the adsorption of protein, a pH value above 9.0 is not preferred. The most preferred pH value is around It is desired that the particle size of the apatite used be as uniform as possible, however, apatite particles D0 genarally used as the polishing agent for a dentifrice are adequate for this particular purpose. Apatite having a particle size of 2 to 200 microns is preferred because it is easy to handle. The amount of the apatite used is 10 to 100 times as large as the amount of protein. For efficient agitation, it is desired that a larger amount of water be used with respect to the amount of the apatite used.
The amount of water is adjusted in such a manner that the solid content in the reaction phase amounts from 4 to It is preferred that virtually equivalent amounts of protein and glucanase be used. A large difference in the amount of both components, in particular, use of glucanase in a smaller amount with respect to protein, should be avoided since there will be a drop in the titer of the resulting immobilized enzyme. Generally, available glutaraldehyde is preferred for the bifunctional aldehyde used. The amount of the bifunctional aldehyde used is a factor which produces the greatest influence upon the titer of the immobilized enzyme. Too small an amount of the glutaraldehyde to be added generally causes the immobilized enzyme to show a low bonding force to apatite and to suffer considerable deactivation with the passage of time.
A large amount of glutaraldehyde results in a reduction in the titer of the obtained immobilized enzyme, and a further increase in the amount thereof leads to deactivation of that enzyme. Although the amount of glutaraldehyde 4 used is slightly different depending upon the type of glucanase and protein, generally, the amount of glutaraldehyde used is 3 to 60mg, preferably 6 to 20mg per gram of protein used. The reaction involved is effected at a temperature not exceeding room temparature, preferably at around While vigorous stirring is applied to a suspension in which to protein, glucanase and apatite coexist, an aqueous 6 solution of glutaraldehyde is slowly added dropwise thereto. After the dropwise addition, stirring is carried out at the same temperature for several hours to complete the reaction. After the reaction has been completed, filtration is applied. The obtained apatite is amply washed with water or the buffer solution used for removal of entrained protein and enzyme, and is then maintained at a lower temperature or freeze-dried for solidification and then kept at the room temperature.
(O This immobilized apatite according to the present invention may also be produced in the following manner.
Apatite is added under sufficient agitation to an aqueous or buffer solution in which the protein is dissolved, whereby the protein is adsorbed to the apatite for saturation. Thereafter, the apatite which has adsorbed the I S protein is collected and added to water or buffer solution in which glutaraldehyde is dissolved. While the resulting solution is vigorously stirred, an aqueous solution of glutaraldehyde is slowly added dropwise thereto. The "Q temperature and other conditions applied to this end are the same as mentioned in the foregoing.
The apatite having immobilized glucanase obtained in this manner, is stable, suffers less change with time and is easy to handle.
It has been clarified that apazite well absorbs a certain type of protein. It is also known that 7
*A
.i_ glutaraldehyde is used as the crosslinking agent for the immobilization of enzyme. Although the mechanism through which the immobilization of glucanase with apatite is achieved is stil unclear, it is presumed that the vdsorption of protein, which is easily adsorbed by apatite, to apatite takes place simultaneously with crosslinking of protein and glucanase, thus yielding the immobilized apatite.
For a better understanding of the invention and 0O to show how the same may be put into effect, reference will be made by a way of example to the following working example.
Example 1. Immobilization of Levanase to Hydroxyapatite.
One hundred (100) mg of lysozyme and 100mg of levanase were dissolved in 50m2 of pure water, and 2g of polishing agent hydroxyapatite was added to the resulting solution, followed by cooling down to 4*c. While maintaining the temperature at 4°C and vigorously stirring, 2mR of solution containing 28mg of glutaraldehyde in O 100me of water was slowly added dropwise. After the completion of dropwise addition, stirring was carried out for 2 hours while maintaining the temperature at 4°C. Subsequent centrifugation gave a solid product, which was inturn washed under agitation three times with 50ml of pure water to obtain immobilized hydroxyapatite in an undried state. (Optionally, this product may c t 1 8 i.~ be used as such). Freeze-drying gave 2.05g of a powder.
To lg of that powder, 1Ome of a potssium phosphate buffer solution having a pH value of 6.8 and a concentration of 1 mole was added. Stirring was carried out for lhr., and centrifugation was then applied to collect the filtrate. The same operation was repeated twice with the residue. The obtained filtrates were combined to determine the protein content bythe lowry method. After water washing, the residue was dried to measure to weight (0 thereof. In consequence, it was ascertained that 11.7mg of protein was bonded to per gram of hydroxyapatite.
Measurement of the levanase activity of the immobilized hydroxyapatite in the undried state by following method indicated that 0.47g of levan was decomposed per gram of protein bonded to hydroxyapatite.
Example 2. Immobilization of levanase to fluoroapatite.
The same conditions as in Ex.1 were applied, except that fluoroapatite was used in place of hydroxyapatite, to obtain 2.05g of a freeze-dried product. Measurement of the Sbonded protein, effected in the same manner as in Ex.l, indicated that 13.4mg of protein was bonded to per gram V of fluoroapatite. The results of measurement of the "t I levanase activity of undried fluoroapatite also indicated that O.54g of levan was decomposed by per gram of the bonded protein.
Example 3. Immobilization of mutanase to hydroxyapatite.
The same conditions as in Ex.l, except that mutanase 9 il; ri-: was used in place of levanase, were applied to obtain an immobilized hydroxyapatite. Decomposition was effected in the same manner as in Ex.l. As a result, it was confirmed that 15.0mg of protein was bonded to per gram of hydroxyapatite. The mutanase activity of the product was measured by a method of measuring mutanase activity to be described later. In consequence, it was ascertained that 0.48g of mutan was decomposed by gram of the protein bonded to hydroxyapatite.
Example 4. Immobilization of mutanase to fluoroapatite The same conditions as in Ex.2, except for the fact that mutanase was used in place of levanase, was 0 0 S applied to obtain an immobilized fluoroapatite product.
The results of analysis and measurement of the titer thereof, effected in the same manner as in Ex.3, indicated a S° that 17 may of protein was bonded to gram of fluoroapatite, and 0.45g of mutan was decomposed by gram of the bonded o protein.
Example 5. Immobilization of dextranase to hydroxyapatite r tO Five(5)g of hydroxyapatite used as polishing agent, and 50mf of a potassium phosphate buffer solution having a concentration of 0.05 moles and a pH value of 6.8 were added to a mixture of 50mg of lysozyme with of dextranase. The resulting product was cooled down to 4°C and was vigorously stirred. While maintaining that temperature, 125P of a 0.2% aqueous solution of 10 glutaraldehyde was added dropwise under agitation, followed by additional stirring for 5hr. The reaction product was collected by filtration and was washed three times with lOOmi of the aforesaid buffer solution to obtain immobilized hydroxyapatite in undried state. Freezedrying yielded 5.07g of powdery dextranase immobilized hydroxyapatite.
One(l) ml of the undried immobilized hydroxyapatite was centrifuged to obtain a precipitate.
Two(2)m? of a potassium phosphate buffer solution having a concentration of 1 mole and a pH value of 6.8 was added to the precipitate, and the resulting solution was stirred for 3hr for the desorption of the bonded protein, I followed by centrifugation. With the resulting precipitate, t t the same operation was repeated. The filtrates were S' combined to measure the amount of the protein contained therein by the lowry method, and the precipitates were Swashed with water and then dried to measure the weight thereof. As a result, it was observed that 13.8mg I ^O of protein was bonded to gram of hydroxyapatite. The results of measuring dextranase activity by a dextranase t activity measuring method to be described later indicated that 0.415g of dextran was decomposed by gram of the bonded protein.
Example 6. Immobilization of dextranase to fluoroapatite The same preparation method, analysis and titer 11 measurement as in Ex.5 were applied, except for the fact that fluoroapatite was employed in place hydroxyapatite, thereby obtaining 5.08g of immobilized fluoroapatite in which 15.nag of protein was bonded to gram of fluoroapatite, and 0.43g of dextran was decomposed per gram of the bonded protein.
The results obtained under varied conditions are set forth in Table 1. The conditions for treatment are the same as in the foregoing examples.
f( Measurement of the Titers of Enzymes.
One(l)m? of the undried immobilized apatite obtained in each experiment was added to lOm of a 1% solution of the corresponding substrate. After the o resulting solution had been stirred at 37°C for 2hr., the amount of the monomer formed therein was measured.
ao Apart from this, the protein bonded to Imt of the undried immobilized apatite was determined by the aforesaid I eo method. The titer of each immobilized enzyme was then expressed in terms of the amount of the monomer per gram |P Q0 of the protein bonded to each apatite.
The substrates used were dextran for dextranase, mutan for mutanase and levan for levanase. The amounts of dextranase and mutanase were determined from the glucose obtained through decomposition by the glucose oxidase method, and the amount of levanase was determined from the fluctose obtained through decomposition with 12 the use of high performance liquid chromatography (a column: sugar pack I) in the conventional manner.
Bonded Protein Elution Testing The immobilized apatite obtained was packed in a column and washed with varied concentrations of a buffer solution to determine the concentration for elution of bonded protein. The bonding force of protein to apatite was then expressed in terms of the obtained measurement.
Table 2 shows the results obtained from the hydroxyapatite )0 which dextranase is immobilized. The eluate used was a potassium phosphate buffer solution having a concentration from 1 millimole to 1 mole and a pH value of 6.8, and the control applied was hydroxyapatite to which only *r c dextranase was bonded. The results indicate that the Sprefirred carrier is lysozyme.
at .r Activity of Immobilized Enzymes with Elapsed Time Examination was made of changes in activity with elapsed time of several samples of the immobilized apatite obtained according to the present invention. The samples 'i used were all the undried immobilized products. The activity of each sample was measured by the aforesaid method. The results are set forth in Table 3. It was found that the obtained immobilized apatites all increased their activity from the first with the passage of time and showed the peak activity value after a certain period, following which there was a gradual drop in activity.
13 I j 1 It accordance with the present invention, glucanase can be immobilized in apatite through a very simple operation. The immobilized apatite is easy to handle, is stable and suffers less change with time. In addition, the apatite product of the present invention combines the polishing property of apatite with an ability to decompose polysaccharides responsible for dental caries.
Accordingly, use of the product as a dentifrice is preferred in view of the desire for prevention of dental caries.
\Q For these reasons, the invention is highly advantageous for maintaining good oral hygiene.
As many apparently widely different embodiments of the present invention can be made without departing from the spirit and scope thereof, it is to be understood that the invention is not limited to the specific embodiments thereof except as defined in the appended claims.
t r St I t** C: t 1 14 *4t S 4 4 .4a 4. 4. TABLE 1 NO. Type Amt. of Protein Type Amt. of GlucanaselType Amt. of Apatite Glutaraldehyde 1 j i i I 7 8 9 11 12 iO13 14 16 17 18 19 21 22 S23 24 lysozyme 0.lg lysozyie 0.I g lysozyme 0.lg casein 0.lg cytochrome C 0.lg lysozyme 0.1-g lysozyme ,O.lg lysozyme 0.lg lysozyme 0.lg lysozyme 0.lg lysozyme 0.2g albumin 0.05g lysozyme 0.05g lysozyme 0.05g lysozyme 0.025g lysozyme. 0.0125g lysozyme 0.05g cytochrome C 0.05g lysozyme 0.05g levanase 0.lg mutanase 0.lg levana-se 0.lg levanase 0.lg levanase 0.lg levanase 0.lg levanase 0.lg mutanase 0.lg levanase 0.lg mutanase 0.lg dextranase 0.2g deiztranase 0.05g dextranase 0.2g dextranase 0.2g dextranase 0.025g dextranase 0.0125g dextranase 0.05g dextranase 0.05g dextranase 0.05g h ydroxyapatite fluoroapatite hydroxyapatite hydroxyapatite hydroxyapatite fluoroapatite hydroxyapatite hydroxyapatite fluoroapatite hydroxyapatite hydroxyapatite hydroxyapatite hydroxyapatite hydroxyapatite hydroxyapatite hydroxyapatite fluoroapatite hydroxyapatite fluoroapatite 2g 2g 2g 2g 2g 2g 2g 2g 2g 2g 5g 5g 5g 5g 2. 5g 2. 5g 5g 5g 5g 1. 12mg 1. 12mg 0. 56mg 0.56mg 0. 56mg 2. 24mg 4.48mg 8. 96mg 18.0Omg 18.0mg 0 1 0mg 0. 5mg 10Omg 50Omg 50Omg 0. 5mg 0. 135mg 1.0Omg 10. 3mg 14 .7mg 9. 7mg 10.3mg 13.2mg 13. 7mg 15.3mg 16. 4mg 19. 0mg 17.4mg 31.4mg 10. 9mg 9. 94mg 15.2mg 8. 75mg 12 .37mg 10. 5mg 12.16mg 12.3mg 0 47g 0:47g 0.42g 0.44g 0. 49g 0.45g 0.32g 0. 13g 0.04g 0.02g 0. 0.51g 0. 62g 0.,46g 0. 06g 0 0.50~g 0.46g 0. 53g A: total bonded protein/grams of apatite; B: amount of substrate decomposition/grams of protein 15 2 1 TABLE 2 Immobilizing Force of Hydroxyapatite to Dextronase Carrier Control Lysozyme Albumin Casein Eluting Concentration 0.08 mol 0.18 mol 0.12 mol 0.15 mol TABLE 3 Change in enzymatic Activity of Immobilized Apatite with Time (specific activity) Io No.
1 ,2 3 .4 6 5
A
B
C
S Just after Preparation 100 100 100 100 100 100 100 100 100 4 C 20 days 213.6 303.3 278.8 241.6 293.0 287.4 4 C 60 days 98.0 110.4 121.9 95.8 112.9 108.7 36°C 20 days 154.0 136.7 150.6 155.0 327.0 320.4 68.4 65.3 58.7 36°C 60 days 70.5 57.2 68.4 70.5 126.8 120.8 27.3 25.8 20.3 A: Levanase only; B: Mutanase only; C: Dextranase only; each preserved in the form of an aqueous solution Pt
I
t i .4 16
Claims (8)
1. A method of preparing an apatite having glucanase immobilized therein, which comprises adding dropwise glutaraldehyde to an aqueous solution in which glucanase, protein and apatite are present in a mixed state, wherein the protein is firmly adsorbed to the apatite prior to the addition of the glutaraldehyde.
2. The method according to claim 1 in which the protein used is lysozyme.
3. The method according to claim 1 or claim 2, wherein the aqueous solution used is a buffer solution having a pH value ranging from 5.6 to
4. The method according to any one of claims 1 to 3, wherein the i amount of glutaraldehyde is 0.3 to 6% relative to the protein.
5. The method according to any one of claims 1 to 4, wherein the S. apatite has a particle size of 2 to 200 microns.
6. The method according to claim 1, wherein a suspension of a S buffer solution is provided, which buffer solution has a pH value ranging from 5.6 to 9.0 and contains equivalent amounts of lysozyme and glucanase and apatite having a particle size of 2 to 200 microns in an amount of to 100 times as large as the amount of lysozyme, and glutaraldehyde in an amount of 0.3% to 6% relative to lysozyme is added dropwise thereto with S the application of cooling and stirring.
7. A method of preparing an apatite having glucanase immobilised therein, which method is substantially as described herein with reference to any one of the Examples.
8. An apatite having glucanase immobilized therein when prepared according to the process of any one of claims 1 to 7. DATED this EIGHTEENTH day of JUNE 1990 Dental Kagaku Kabushiki Kaisha Patent Attorneys for the Applicant SPRUSON FERGUSON LMM/369S
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61091332A JPS62248487A (en) | 1986-04-22 | 1986-04-22 | Apatite containing immobilized glucanase or such and production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7460187A AU7460187A (en) | 1989-01-05 |
AU602149B2 true AU602149B2 (en) | 1990-10-04 |
Family
ID=14023487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74601/87A Ceased AU602149B2 (en) | 1986-04-22 | 1987-06-23 | Apatite immobilized glucanase and the like, and method of preparing the same |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS62248487A (en) |
AU (1) | AU602149B2 (en) |
DE (1) | DE3721441C1 (en) |
FR (1) | FR2617867B1 (en) |
GB (1) | GB2206585A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU643469B2 (en) * | 1989-11-01 | 1993-11-18 | Nippon Shinyaku Co. Ltd. | Stabilized immobilized enzyme |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268174A (en) * | 1988-09-29 | 1993-12-07 | Kabushiki Kaisha Sangi | Antimicrobial hydroxyapatite powders containing hinokitiol, protamine or sorbic acid |
US5009898A (en) * | 1988-09-29 | 1991-04-23 | Kabushiki Kaisha Sangi | Antimicrobial hydroxyapatite powders and methods for preparing them |
US5041236A (en) * | 1989-10-27 | 1991-08-20 | The Procter & Gamble Company | Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases |
US5238843A (en) * | 1989-10-27 | 1993-08-24 | Genencor International, Inc. | Method for cleaning a surface on which is bound a glycoside-containing substance |
DK0425016T3 (en) * | 1989-10-27 | 1996-05-06 | Genencor Int | Antimicrobial method and formulation using type II endoglycosidase and antimicrobial agent |
US5258304A (en) * | 1989-10-27 | 1993-11-02 | Genencor International, Inc. | Method of removing microorganisms from surfaces with Type II endoglycosidase |
US5443832A (en) * | 1990-04-16 | 1995-08-22 | Institut Swisse De Recherches Experimentales Sur Le Cancer | Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response |
JP2000508323A (en) | 1996-04-16 | 2000-07-04 | ノボ ノルディスク アクティーゼルスカブ | Composition for the removal of plaque |
US6413501B2 (en) | 1997-10-17 | 2002-07-02 | Novozymes A/S | Plaque-inhibiting oral compositions |
FR2773170B1 (en) * | 1997-12-31 | 2000-10-13 | Ase & Bio Soc Civ | ENZYMES IMMOBILIZED ON AN ALUMINUM SUPPORT, THEIR PREPARATION METHODS AND THEIR APPLICATIONS |
CN112111479A (en) * | 2020-09-30 | 2020-12-22 | 江苏海洋大学 | Dextranase and hydroxyapatite composite material and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE71142T1 (en) * | 1984-08-02 | 1992-01-15 | Stabra Ag | CARGO ON A PILLAR. |
-
1986
- 1986-04-22 JP JP61091332A patent/JPS62248487A/en active Granted
-
1987
- 1987-06-23 AU AU74601/87A patent/AU602149B2/en not_active Ceased
- 1987-06-29 DE DE3721441A patent/DE3721441C1/en not_active Expired
- 1987-07-01 GB GB08715448A patent/GB2206585A/en not_active Withdrawn
- 1987-07-10 FR FR878709866A patent/FR2617867B1/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU643469B2 (en) * | 1989-11-01 | 1993-11-18 | Nippon Shinyaku Co. Ltd. | Stabilized immobilized enzyme |
Also Published As
Publication number | Publication date |
---|---|
JPS62248487A (en) | 1987-10-29 |
FR2617867A1 (en) | 1989-01-13 |
FR2617867B1 (en) | 1990-03-09 |
GB2206585A (en) | 1989-01-11 |
AU7460187A (en) | 1989-01-05 |
DE3721441C1 (en) | 1988-12-29 |
GB8715448D0 (en) | 1987-08-05 |
JPH0441597B2 (en) | 1992-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU602149B2 (en) | Apatite immobilized glucanase and the like, and method of preparing the same | |
CA1285511C (en) | Apatite immobilized glucanase and the like, and method of preparingthe same | |
Gibbons et al. | Induction of dental caries in gnotobiotic rats with a levan-forming streptococcus and a streptococcus isolated from subacute bacterial endocarditis | |
US4138476A (en) | Plaque dispersing enzymes as oral therapeutic agents by molecular alteration | |
WO1995000110A1 (en) | Composition for oral cavity | |
JPH0764884B2 (en) | Cyclodextrin composition | |
Minah et al. | The in-vitro effect of fungal dextranase on human dental plaque | |
US3940476A (en) | Oral preparations for preventing dental plaque | |
AU599387B2 (en) | Dentifrice compositions comprising hydroxyapatite in which glucanase is immobilized therein | |
Fantl | Thiol groups of blood platelets in relation to clot retraction | |
JP3336688B2 (en) | Oral composition | |
WO1990002544A1 (en) | Composition for oral cavity | |
CA1281658C (en) | Dentifrice compositions | |
JPH0710728A (en) | Composition for oral cavity | |
JP2575156B2 (en) | Skin cosmetics | |
JP2757946B2 (en) | Dextranase adsorbent and method for producing the same | |
Edman et al. | Immobilized L-asparaginase-L-glutaminase from Acinetobacter glutaminasificans in microspheres: some properties in vivo and in an extracorporeal system | |
JPH01250304A (en) | Skin cosmetic | |
JP2546263B2 (en) | Bad breath remover | |
JPS61224963A (en) | Sweetener composition | |
EP0210250A1 (en) | Disinfectant formulation and method of disinfection in vivo | |
Barker et al. | Absorption of a dextranase-concanavalin a conjugate on to hydroxyapatite | |
KR900003746B1 (en) | Method for purification of cyclo dextringlycosyl transferase | |
JPS5846316B2 (en) | Method for removing bitterness from fruit juice containing naringin | |
WO1992006692A1 (en) | Composition for therapeutic, prophylactic or diagnostic use in connection with infections |